

Combined medication that reduces flatulence. It has anti-inflammatory effect, reduces the secretion of hydrochloric acid in the stomach, reduces gas formation in the intestine.
Gvayazulen has a pronounced anti-inflammatory effect, reduces allergic reactions, strengthens the regenerative processes, has an antioxidant effect. Due to the inhibitory effect on the release of histamine from mast cells, cells of the gastric mucosa, inhibits acid secretion.
Dimethicone is a hydrophobic polymeric substance with a low surface tension, which reduces gas formation in the intestine and covers the wall of the alimentary canal with a protective film.
Pharmacokinetics
Data on the pharmacokinetics of the drug Pepsan-R is not provided.
Indications
- gastralgia;
- gastroesophageal reflux disease, grade 0–1;
- increased acidity of gastric juice;
- functional disorders of the gastrointestinal tract, manifested by heartburn, belching, increased gas formation, nausea, constipation and / or diarrhea;
- preparation for X-ray, ultrasound or instrumental examination of the abdominal organs.
Dosing regimen
Assign 1 capsule or sachet 2-3 times / day before meals or in the event of pain. The course of treatment is determined individually.
In preparation for the study of the abdominal cavity, 1 capsule or sachet is prescribed 2-3 times / day on the eve of the study and 1 capsule or sachet in the morning on the study day.
Side effect
Rarely: allergic reactions, pain, bloating.
Contraindications
- children's age up to 14 years;
- hypersensitivity to the drug.
Pregnancy and lactation
Perhaps the use of the drug during pregnancy and during breastfeeding.
Overdose
Possible increased side effects.
Drug interaction
Drug interaction is not established.
Pharmacy sales terms
Terms and conditions of storage
The drug should be stored out of the reach of children at a temperature not higher than 25 ° C. Shelf life of capsules - 4 years, sachet - 2 years.